幼年型复发性呼吸道乳头状瘤术后并发症相关因素分析

沈梦雅, 肖洋, 马丽晶, 等. 幼年型复发性呼吸道乳头状瘤术后并发症相关因素分析[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(4): 312-315. doi: 10.13201/j.issn.2096-7993.2021.04.006
引用本文: 沈梦雅, 肖洋, 马丽晶, 等. 幼年型复发性呼吸道乳头状瘤术后并发症相关因素分析[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(4): 312-315. doi: 10.13201/j.issn.2096-7993.2021.04.006
SHEN Mengya, XIAO Yang, MA Lijing, et al. Analysis of related factors of postoperative complications of Juvenile-onset recurrent respiratory papillomatosis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2021, 35(4): 312-315. doi: 10.13201/j.issn.2096-7993.2021.04.006
Citation: SHEN Mengya, XIAO Yang, MA Lijing, et al. Analysis of related factors of postoperative complications of Juvenile-onset recurrent respiratory papillomatosis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2021, 35(4): 312-315. doi: 10.13201/j.issn.2096-7993.2021.04.006

幼年型复发性呼吸道乳头状瘤术后并发症相关因素分析

  • 基金项目:
    北京市自然基金(No:7182036)、北京市中医局科技发展资金项目(No:JJ-2020-17)和北京市医院管理中心儿科学科协同发展中心专项经费(No:XTCX201823)联合资助
详细信息

Analysis of related factors of postoperative complications of Juvenile-onset recurrent respiratory papillomatosis

More Information
  • 目的  分析幼年型复发性呼吸道乳头状瘤(JORRP)术后并发症形成的原因和相关因素。 方法  对2017-2019年于首都医科大学附属北京同仁医院行手术治疗的170例JORRP患儿进行随访,并回顾性分析患儿的临床资料,记录性别、发病年龄、病灶位置、临床表现、手术方式、气管切开术史、组织病理学结果、手术次数、手术间隔、术后并发症等情况。根据有无术后并发症将患儿分为并发症组和对照组,比较两组间的差异及引起术后并发症的相关因素。 结果  170例患儿中,75例(44.12%)患儿出现术后并发症,并发症组中声带粘连52例(69.33%)、下气道播散37例(49.33%)、喉狭窄25例(33.33%)。初次手术年龄为0.3~14岁,平均总手术次数14.52(1~54)次,平均年手术次数2.93(0.04~18.39)次。并发症组和对照组总手术次数分别为(19.07±13.12)次和(10.97±9.41)次(P < 0.01)。年手术次数≥4次(P = 0.034)、气管切开后(P = 0.007)、经历过低温等离子射频消融手术和和光动力治疗较单纯使用CO2激光(P < 0.01)的患儿更易出现术后并发症。 结论  JORRP术后并发症包括声带粘连、喉气管狭窄、下气道播散等。多次、频繁的手术和气管切开、不同的手术方式与术后并发症密切相关。患儿初次手术年龄较小、年手术次数较多时可能增加术后并发症的风险。
  • 加载中
  • 表 1  并发症组与对照组相关因素比较

    指标 并发症组(n=75) 对照组(n=95) P
    初次手术年龄/岁 3.04 3.10 < 0.01
    每年手术频率/次
      ≥4 21 14 < 0.05
       < 4 54 81
    气管切开
      是 27 17 < 0.01
      否 48 78
    手术方式
      单纯使用CO2激光 55 89 < 0.01
      曾行射频手术等其他治疗 20 6
    下载: 导出CSV
  • [1]

    Hermann JS, Pontes P, Weckx LL, et al. Laryngeal sequelae of recurrent respiratory papillomatosis surgery in children[J]. Rev Assoc Med Bras(1992), 2012, 58(2): 204-208. doi: 10.1590/S0104-42302012000200016

    [2]

    Mitra S, Das A, Ghosh D, et al. Postoperative Systemic Acyclovir in Juvenile-Onset Recurrent Respiratory Papillomatosis: The Outcome[J]. Ear Nose Throat J, 2019, 98(1): 28-31. doi: 10.1177/0145561318823311

    [3]

    Montaño-Velázquez BB, Nolasco-Renero J, Parada-Bañuelos JE, et al. Quality of life of young patients with recurrent respiratory papillomatosis[J]. J Laryngol Otol, 2017, 131(5): 425-428. doi: 10.1017/S0022215117000354

    [4]

    Ilmarinen T, Nissilä H, Rihkanen H, et al. Clinical features, health-related quality of life, and adult voice in juvenile-onset recurrent respiratory papillomatosis[J]. Laryngoscope, 2011, 121(4): 846-851. doi: 10.1002/lary.21332

    [5]

    Ossoff RH, Werkhaven JA, Dere H. Soft-tissue complications of laser surgery for recurrent respiratory papillomatosis[J]. Laryngoscope, 1991, 101(11): 1162-1166.

    [6]

    Perkins JA, Inglis AF Jr, Richardson MA. Iatrogenic airway stenosis with recurrent respiratory papillomatosis[J]. Arch Otolaryngol Head Neck Surg, 1998, 124(3): 281-287. doi: 10.1001/archotol.124.3.281

    [7]

    Preuss SF, Klussmann JP, Jungehulsing M, et al. Long-term results of surgical treatment for recurrent respiratory papillomatosis[J]. Acta Otolaryngol, 2007, 127(11): 1196-201. doi: 10.1080/00016480701200350

    [8]

    Saleh EM. Complications of treatment of recurrent laryngeal papillomatosis with the carbon dioxide laser in children[J]. J Laryngol Otol, 1992, 106(8): 715-718. doi: 10.1017/S0022215100120663

    [9]

    Scatolini ML, Labedz G, Cocciaglia A, et al. Laryngeal sequelae secondary to surgical treatment for recurrent respiratory papillomatosis in children[J]. Int J Pediatr Otorhinolaryngol, 2020, 130: 109815. doi: 10.1016/j.ijporl.2019.109815

    [10]

    Mesolella M, Motta G, Laguardia M, et al. Papillomatosis of the larynx: treatment with CO2 laser[J]. B-ENT, 2006, 2(2): 51-54.

    [11]

    Omland T, Akre H, Lie KA, et al. Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles[J]. PLoS One, 2014, 9(11): e113584. doi: 10.1371/journal.pone.0113584

    [12]

    李英丽, 吴明哲, 柴晓明, 等. 幼年型喉乳头状瘤支气管及肺内播散的CT表现[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(10): 767-769. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201810011.htm

    [13]

    Kim IA, Long J. Laryngotracheal stenosis as a complication of photodynamic therapy[J]. Ann Otol Rhinol Laryngol, 2015, 124(6): 495-498. doi: 10.1177/0003489415570930

    [14]

    Derkay CS, Bluher AE. Recurrent respiratory papillomatosis: update 2018[J]. Curr Opin Otolaryngol Head Neck Surg, 2018, 26(6): 421-425. doi: 10.1097/MOO.0000000000000490

    [15]

    张显香, 王军, 肖洋, 等. 幼年型复发性呼吸道乳头状瘤病的远期疗效分析[J]. 中华耳鼻咽喉头颈外科杂志, 2018, 53(11): 825-829. doi: 10.3760/cma.j.issn.1673-0860.2018.11.006

    [16]

    Xiao Y, Zhang X, Ma L, et al. Long-term outcomes of juvenile-onset recurrent respiratory papillomatosis[J]. Clin Otolaryngol, 2021, 46(1): 161-167. doi: 10.1111/coa.13635

    [17]

    Carifi M, Napolitano D, Morandi M, et al. Recurrent respiratory papillomatosis: current and future perspectives[J]. Ther Clin Risk Manag, 2015, 11: 731-738.

    [18]

    Friedrich G, Dikkers FG, Arens C, et al. Vocal fold scars: current concepts and future directions. Consensus report of the Phonosurgery Committee of the European Laryngological Society[J]. Eur Arch Otorhinolaryngol, 2013, 270(9): 2491-2507. doi: 10.1007/s00405-013-2498-9

    [19]

    Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis[J]. APMIS, 2010, 118(6/7): 450-454.

    [20]

    Ivancic R, Iqbal H, deSilva B, et al. Current and future management of recurrent respiratory papillomatosis[J]. Laryngoscope Investig Otolaryngol, 2018, 3(1): 22-34. doi: 10.1002/lio2.132

    [21]

    魏锐文, 范敏, 崔榕, 等. CO2激光与等离子两种方法治疗喉乳头状瘤的疗效对比[J]. 四川医学, 2017, 38(7): 787-790. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX201707024.htm

    [22]

    Lieder A, Khan MK, Lippert BM. Photodynamic therapy for recurrent respiratory papillomatosis[J]. Cochrane Database Syst Rev, 2014, 6: CD009810.

    [23]

    Hung WC, Lo WC, FANG KM, et al. Longitudinal Voice Outcomes Following Serial Potassium Titanyl Phosphate Laser Procedures for Recurrent Respiratory Papillomatosis[J]. Ann Otol Rhinol Laryngol, 2020. [Online ahead of print]

  • 加载中
计量
  • 文章访问数:  712
  • PDF下载数:  194
  • 施引文献:  0
出版历程
收稿日期:  2020-11-29
刊出日期:  2021-04-05

目录